TOKENPOST
1 min read
Add as a preferred source on Google

Sonoma Pharmaceuticals Posts $7.17 Million in Fiscal Q2 Revenue

The company recorded a basic and diluted GAAP net loss per share of $0.01 for the quarter ended Sept. 30, 2026.

By John Kim
Published
A glass vial rests on one pan of a brass balance / TokenPost.ai
A glass vial rests on one pan of a brass balance / TokenPost.ai

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) recorded $7.174 million in revenue and a GAAP net loss per share of $0.01 on both a basic and diluted basis for its second fiscal quarter of 2027, which ended Sept. 30, 2026.

The company announced the results on Nov. 10, 2026.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…